To identify downstream targets of MEK1/MEK2 involved in intestinal tumor progression, we analyzed the transcriptional profile of MEK1DD- and MEK2DD-expressing IEC-6 cells using Affymetrix GeneChip arrays. Here, MAP2K2 is linked to intestinal neoplasm.